Michael Scolaro

Michael Scolaro

Oct 06, 2017

Group 6 Copy 216
1
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

Building an active surveillance system for lead in Northeastern wildlife

Many species of wildlife are exposed to lead in the environment, sometimes with devastating consequences. Some...

NoAAC Longitudinal Registry of Treatment Outcomes in iSGS

Idiopathic subglottic stenosis (iSGS) is a rare and life-threatening disease involving airway obstruction...

Can perfluorocarbon liquids remove benzo(a)pyrene, a model carcinogen from cells?

Lung cancer is the single largest cause of cancer mortality, accounting for about 19% of all cancer deaths...

Backer Badge Funded